Compelling evidence for unconditional shift to dolutegravir

Lancet HIV. 2022 Aug;9(8):e523-e524. doi: 10.1016/S2352-3018(22)00164-3.

¹ Department of Haematology and Molecular Medicine, National Health Laboratory Services, Johannesburg, South Africa; Department of Haematology and Molecular Medicine, University of the Witwatersrand, Johannesburg, South Africa; Charlotte Maxeke Johannesburg Academic Hospital, 2193 Parktown, Johannesburg, South Africa. Electronic address: kim.steegen@nhls.ac.za.
² Department of Haematology and Molecular Medicine, National Health Laboratory Services, Johannesburg, South Africa; Department of Haematology and Molecular Medicine, University of the Witwatersrand, Johannesburg, South Africa; Charlotte Maxeke Johannesburg Academic Hospital, 2193 Parktown, Johannesburg, South Africa.

No abstract available

Publication types